Close Menu

This article in the Guardian describes a DNA-based vaccine for multiple sclerosis that's gone through in human trials and "has been declared a success by doctors in America after tests on patients revealed signs that their condition had improved," according to the story. The vaccine contains DNA responsible for producing myelin, which serves to prevent the immune system from going haywire and causing MS.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The chief executive of the National Health Service in England is to call for tumor-agnostic drugs to be "fast-tracked," according to the Times.

Researchers in Australia are sequencing the Wollemi pine tree to try to protect it from extinction, Australia's ABC News reports.

Computerworld ranks Illumina as one of the top midsize organizations to work at in IT.

In Genome Research this week: links between biological aging and mutations affecting epigenetic regulators; long-read sequencing-based strategy to map chromatin accessibility; and more.